Company news

Gilead Sciences, Inc. news in 2025

Gilead Sciences, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Gilead to Present Latest Advancements Across Primary Biliary Cholangitis and Viral Hepatitis

April 28, 2025

Contineum Therapeutics Appoints Timothy Watkins, M.D., M.Sc., as Chief Medical Officer and Head of Development

April 27, 2025

Gilead Sciences Announces First Quarter 2025 Financial Results

April 23, 2025

Trodelvy® Plus Keytruda® Demonstrates a Statistically Significant and Clinically Meaningful Improvement in Progression Free Survival in Patients With Previously Untreated PD-L1+ Metastatic Triple-Negative Breast Cancer

April 20, 2025

Gilead Sciences to Release First Quarter 2025 Financial Results on Thursday, April 24, 2025

April 9, 2025

Gilead Presents New HIV Treatment and Cure Research Data at CROI 2025, Including an Investigational Long-Acting, Twice-Yearly Therapy Option

March 11, 2025

First Clinical Data for Gilead’s Investigational Once-Yearly Lenacapavir for HIV Prevention Presented at CROI 2025 and Published in The Lancet

March 10, 2025

European Medicines Agency Validates Gilead’s Marketing Authorization Application and EU-Medicines for All Application for Twice-Yearly Lenacapavir for HIV Prevention

February 23, 2025

Gilead’s Seladelpar Granted Conditional European Marketing Authorization for the Treatment of Primary Biliary Cholangitis

February 19, 2025

U.S. FDA Accepts Gilead’s New Drug Applications for Twice-Yearly Lenacapavir for HIV Prevention Under Priority Review

February 17, 2025

Gilead Sciences Announces Fourth Quarter and Full Year 2024 Financial Results

February 10, 2025

Gilead Sciences Announces 2.6 Percent Increase in First Quarter 2025 Dividend

February 10, 2025

Gilead Sciences to Release Fourth Quarter & Full Year 2024 Financial Results on Tuesday, February 11, 2025

January 27, 2025

Gilead and LEO Pharma Enter Into Strategic Partnership to Accelerate Development of Oral STAT6 Program With Potential in Multiple Inflammatory Diseases

January 10, 2025

← Newer news releases

Calls in 2025

Decks in 2025